Impact of exacerbations on lung function, resource utilization, and productivity: results from an observational, prospective study in adults with uncontrolled asthma

被引:5
|
作者
Wisnivesky, Juan [1 ,2 ]
Federmann, Emily [1 ]
Eckert, Laurent [3 ]
West, Erin [4 ]
Amand, Caroline [3 ]
Kamar, Driss [5 ]
Teper, Ariel [6 ]
Khan, Asif H. [3 ]
机构
[1] Icahn Sch Med Mt Sinai, Div Gen Internal Med, Box 1087,One Gustave L Levy Pl, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, Div Pulm & Crit Care Med, New York, NY 10029 USA
[3] Sanofi, Chilly Mazarin, France
[4] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland
[5] Ividata Life Sci, Levallois Perret, France
[6] Sanofi, Bridgewater Township, NJ USA
关键词
Forced expiratory volume; symptom exacerbation; airway disease; asthma exacerbations; healthcare resource utilization; DECLINE;
D O I
10.1080/02770903.2022.2130800
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Exacerbations have a major impact on the well-being of patients with uncontrolled asthma. This study evaluated lung function, healthcare resource utilization (HCRU), and productivity loss following asthma exacerbations.Methods: This single-center, observational, prospective cohort study recruited US patients presenting clinically with an acute asthma exacerbation; a reference group without exacerbations was included for comparison. Lung function (forced expiratory volume in 1 second [FEV1]) was collected at baseline, daily during Month 1, and monthly for Months 2-5, and reported as FEV1 percent predicted (FEV(1)pp). HCRU (outpatient visits to a healthcare practitioner, emergency room [ER] visits, and hospitalizations for asthma), oral corticosteroid (OCS) use, and asthma-related work/school absence were collected monthly for 6 months.Results: Overall, 150 patients were recruited (exacerbation: n=102; reference: n=48; mean [SD] age: 42.7 [15.2] and 49.6 [12.4] years; female: 73% and 71%). In both groups, similar trends were observed in FEV1, with significant improvement from baseline to Week 1 (p<0.05), followed by a continuous decline. FEV(1)p was 7.7% lower at baseline and 8.6% lower at Month 5 in the exacerbation group versus the reference group. The exacerbation group had significantly higher rates of OCS prescription during follow-up versus reference group (p=0.04). Over half (52.9%) of patients in the exacerbation group had a recurrent exacerbation during follow-up, increased HCRU (outpatient visits, ER visits, and hospitalizations), and impaired productivity.Conclusion: Although patients with exacerbations had rapid recovery of lung function, this was not maintained and declined faster than in patients without exacerbations. Additionally, patients experienced increased HCRU after exacerbations.
引用
收藏
页码:1072 / 1079
页数:8
相关论文
共 50 条
  • [1] Benralizumab Reduces Exacerbations And Improves Lung Function In Adults With Uncontrolled Eosinophilic Asthma
    Castro, M.
    Gossage, D. L.
    Ward, C. K.
    Wu, Y.
    Khatri, D. B.
    Molfino, N. A.
    Raible, D. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [2] Impact of Chronic Migraine on Health Resource Utilization, Quality of Life, and Work Productivity: Baseline Results from a Prospective, Observational Study (PREDICT)
    Boudreau, Guy
    Becker, Werner J.
    Graboski, Corrie
    Ong-Lam, May
    Stewart, Bradley
    Davidovic, Goran
    CEPHALALGIA, 2017, 37 : 105 - 105
  • [3] Late-breaking abstract: A phase 2 study of benralizumab on exacerbations, lung function, and asthma control in adults with uncontrolled eosinophilic asthma
    Castro, Mario
    Wenzel, Sally
    Kolbeck, Roland
    Khatry, Deepak
    Christine, Ward
    Wu, Yanping
    van der Merwe, Rene
    Bleecker, Eugene
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [4] Impact of OnabotulinumtoxinA on Quality of Life, Health Resource Utilization, and Work Productivity in People with Chronic Migraine: Interim Results from a Prospective, Observational Study (PREDICT)
    Boudreau, G.
    Becker, W. J.
    Graboski, C.
    Ong-Lam, M.
    Finkelstein, I
    Christie, S.
    Bhogal, M.
    Davidovic, G.
    HEADACHE, 2018, 58 : 94 - 94
  • [5] Prediction of Asthma Exacerbations in Elderly Adults: Results of a 1-Year Prospective Study
    Park, Heung-Woo
    Kim, Tae-Wan
    Song, Woo-Jung
    Kim, Sae-Hoon
    Park, Hye-Kyung
    Kim, Sang-Heon
    Kwon, Yong Eun
    Kim, Tae-Bum
    Lee, Byung-Jae
    Jee, Young-Koo
    Choi, Byoung Whui
    Cho, Sang-Heon
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2013, 61 (09) : 1631 - 1632
  • [6] Impact of OnabotulinumtoxinA on Quality of Life, Health Resources Utilization, and Work Productivity in People With Chronic Migraine: Interim Results From a Prospective, Observational Study (PREDICT)
    Boudreau, Guy
    Becker, Werner J.
    Graboski, Corrie
    Ong-Lam, May
    Finkelstein, Ian
    Christie, Suzanne
    Bhogal, Meetu
    Davidovic, Goran
    NEUROLOGY, 2019, 92 (15)
  • [7] The acute impact of a hematopoietic allograft on lung function and inflammation: a prospective observational study
    Enocson, Alexandra
    Hubbard, Richard
    McKeever, Tricia
    Russell, Nigel
    Byrne, Jennifer
    Das-Gupta, Emma
    Watson, Lynne
    Fogarty, Andrew W.
    BMC PULMONARY MEDICINE, 2013, 13
  • [8] The acute impact of a hematopoietic allograft on lung function and inflammation: a prospective observational study
    Alexandra Enocson
    Richard Hubbard
    Tricia McKeever
    Nigel Russell
    Jennifer Byrne
    Emma Das-Gupta
    Lynne Watson
    Andrew W Fogarty
    BMC Pulmonary Medicine, 13
  • [9] Impact of enzyme replacement therapy on survival in adults with Pompe disease: results from a prospective international observational study
    Deniz Güngör
    Michelle E Kruijshaar
    Iris Plug
    Ralph B D’Agostino
    Marloes LC Hagemans
    Pieter A van Doorn
    Arnold JJ Reuser
    Ans T van der Ploeg
    Orphanet Journal of Rare Diseases, 8
  • [10] Impact of enzyme replacement therapy on survival in adults with Pompe disease: results from a prospective international observational study
    Gungor, Deniz
    Kruijshaar, Michelle E.
    Plug, Iris
    D'Agostino, Ralph B., Sr.
    Hagemans, Marloes L. C.
    van Doorn, Pieter A.
    Reuser, Arnold J. J.
    van der Ploeg, Ans T.
    ORPHANET JOURNAL OF RARE DISEASES, 2013, 8